🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaoxia Yang

Zunyi Medical University

ORCID: 0000-0003-3618-510X

Also affiliated with Shandong Provincial Hospital, Ningxia Medical University, Ningxia Medical University General Hospital, Shandong First Medical University, Gaozhou People's Hospital, Affiliated Hospital of Zunyi Medical College

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival”.

VLA4-Targeted Nanoparticles Hijack Cell Adhesion–Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2839

N/A

0.948DataRank · unranked

27 citations

Michael J. Scott, John S. Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan +12 more

Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer

Theranostics(2020)10.7150/thno.44523

N/A

0DataRank · unranked

41 citations

Michael H. Ross, Francesca Fontana, Xinming Su, Ariel Gabay, Gregory C. Fox +12 more

Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways

Theranostics(2021)10.7150/thno.60757

N/A

0DataRank · unranked

11 citations

Matthew Mixdorf, Lynne Marsala, Julie L. Prior, Xiaoxia Yang, Grace Cui +6 more